Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × amivantamab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor, Adult 1 Neoplasm Metastasis 1 Locally Recurrent Skin Squamous Cell Carcinoma 1

Interventions

pembrolizumab 3 osimertinib 1 leronlimab 1 amivantamab 1 Valganciclovir 1 Radiotherapy 1 Proton Therapy 1 Paclitaxel 1 Lacteol 1 Docetaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06507306 2026-02-06

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Kumquat Biosciences Inc.

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡